Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma
Katey S.S. Enfield(The Francis Crick Institute), Wan L. Lam(University of British Columbia), John C. English(University of British Columbia Hospital), Daiana D. Becker‐Santos(BC Cancer Agency), Daniel Lu, Fraser Johnson(The Netherlands Cancer Institute), Megan Fuller, William W. Lockwood(University of British Columbia), Stephen Lam(University of British Columbia), David A. Rowbotham(BC Cancer Agency), Rocky Shi, Igor Jurišica(University Health Network), Raj Chari(National Institutes of Health), Erin A. Marshall(BC Cancer Agency), Kevin W. Ng(The Francis Crick Institute), Katy Milne(University of Victoria), Aly Karsan(University of British Columbia), Sara Rahmati(University of Toronto), Zhaolin Xu(Dalhousie University), Calum MacAulay(BC Cancer Agency)
Cited by 73
Related Papers
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
Protein complex prediction via cost-based clustering
|Bioinformatics|2004|668
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
|The Lancet Oncology|2013|419
Cas9 gRNA engineering for genome editing, activation and repression
|Nature Methods|2015|356
NAViGaTOR: Network Analysis, Visualization and Graphing Toronto
|Bioinformatics|2009|272